BMC cancer
Journal
Overview
publication venue for
-
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report.
2015
-
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer..
24.
2024
-
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study..
23.
2024
-
A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)..
23.
2023
-
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)..
23.
2023
-
Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study - (NCT05103020) - study protocol..
23.
2023
-
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial..
22.
2022
-
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma..
22.
2022
-
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study..
22.
2022
-
CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure..
21.
2021
-
Acute limb ischemia in a cancer patient has high morbidity, high mortality, and atypical presentation: a tertiary cancer center's retrospective study..
21.
2021
-
Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy..
21.
2021
-
Low dose environmental radon exposure and breast tumor gene expression..
20.
2020
-
Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β..
20.
2020
-
Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection..
20.
2020
-
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer..
19.
2019
-
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma..
19.
2019
-
Silencing of ANKRD12 circRNA induces molecular and functional changes associated with invasive phenotypes..
19.
2019
-
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial..
19.
2019
-
A genome wide SNP genotyping study in the Tunisian population: specific reporting on a subset of common breast cancer risk loci..
18.
2018
-
Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior..
18.
2018
-
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience..
18.
2018
-
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia..
18.
2018
-
RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis..
18.
2018
-
Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up..
18.
2018
-
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer..
17.
2017
-
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI..
17.
2017
-
Metabolic dysregulation and cancer mortality in a national cohort of blacks and whites..
17.
2017
-
Treatment of gastrointestinal stromal tumours in paediatric and young adult patients with sunitinib: a multicentre case series..
17.
2017
-
Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer..
17.
2017
-
Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer..
17.
2017
-
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer..
16.
2016
-
The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients..
16.
2016
-
Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients..
16.
2016
-
CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer..
16.
2016
-
The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome..
16.
2016
-
A qualitative study of women's views on overdiagnosis and screening for thyroid cancer in Korea..
15.
2015
-
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management..
15.
2015
-
SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction..
15.
2015
-
How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations..
15.
2015
-
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity..
15.
2015
-
Characteristics of attitude and recommendation of oncologists toward exercise in South Korea: a cross sectional survey study..
15.
2015
-
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors..
15.
2015
-
3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma..
14.
2014
-
Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species..
14.
2014
-
Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization..
13.
2013
-
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death..
12.
2012
-
External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases..
12.
2012
-
SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors..
12.
2012
-
Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial..
12.
2012
-
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer..
12.
2012
-
Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study..
11.
2011
-
A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France..
10.
2010
-
Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer..
10.
2010
-
Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness..
10.
2010
-
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes..
10.
2010
-
The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design..
10.
2010
-
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma..
9.
2009
-
Role of KCNMA1 gene in breast cancer invasion and metastasis to brain..
9.
2009
-
Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer..
9.
2009
-
The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas..
9.
2009
-
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma..
9.
2009
-
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis..
9.
2009
-
Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier..
8.
2008
-
Methylation alterations are not a major cause of PTTG1 misregulation..
8.
2008
-
Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma..
8.
2008
-
COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ..
8.
2008
-
Gene x Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study..
6.
2006
-
TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells..
6.
2006
-
Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma..
6.
2006
-
Kinetics of cancer: a method to test hypotheses of genetic causation..
5.
2005
Identity
ISO Abbreviation
Linking ISSN
Electronic International Standard Serial Number (EISSN)